Lupin secures tentative FDA approval for Xywav oral solution generic
Global pharma leader, Lupin Limited, proudly announced its tentative approval from the United States Food and Drug Administration (U.S. FDA). This nod gives green light to its Abbreviated New Drug Application for Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution, 0.5 g/mL. Aiming to tap into the lucrative market, Lupin’s product is set to be […]